273 related articles for article (PubMed ID: 15635725)
41. Improved synthesis and pharmacological evaluation of racemic 11 -demethylcalanolide A.
Wang L; Zhang XQ; Chen HS; Tao PZ; Li Y; Bai Y; Hu JP; Ma T; Xing ZT; Peng ZG; Zhou CM; Gao Q; Liu G
Yao Xue Xue Bao; 2008 Jul; 43(7):707-18. PubMed ID: 18819474
[TBL] [Abstract][Full Text] [Related]
42. [Ester derivatives of nucleoside inhibitors of reverse transcriptase: II. Molecular systems for combined therapy with 3'-azido-3'-deoxythymidine and 2',3'-didehydro-3'-deoxythymidine].
Berezovskaia IuV; Chudinov MV
Bioorg Khim; 2005; 31(5):451-65. PubMed ID: 16245688
[TBL] [Abstract][Full Text] [Related]
43. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors.
Rawal RK; Prabhakar YS; Katti SB; De Clercq E
Bioorg Med Chem; 2005 Dec; 13(24):6771-6. PubMed ID: 16198576
[TBL] [Abstract][Full Text] [Related]
44. Effects of human interleukin 7 on HIV-1 replication in monocyte-derived human macrophages.
Song H; Nakayama EE; Shioda T
AIDS; 2006 Apr; 20(6):937-9. PubMed ID: 16549982
[TBL] [Abstract][Full Text] [Related]
45. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
[TBL] [Abstract][Full Text] [Related]
46. Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages.
Aquaro S; Svicher V; Ceccherini-Silberstein F; Cenci A; Marcuccilli F; Giannella S; Marcon L; Caliò R; Balzarini J; Perno CF
J Antimicrob Chemother; 2005 Jun; 55(6):872-8. PubMed ID: 15845785
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, in vitro and in vivo release kinetics, and anti-HIV activity of a sustained-release prodrug (mPEG-AZT) of 3'-azido-3'-deoxythymidine (AZT, Zidovudine).
Li W; Chang Y; Zhan P; Zhang N; Liu X; Pannecouque C; De Clercq E
ChemMedChem; 2010 Nov; 5(11):1893-8. PubMed ID: 20936623
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and immunomodulatory activity of [60]fullerene-tuftsin conjugates.
Xu Y; Zhu J; Xiang K; Li Y; Sun R; Ma J; Sun H; Liu Y
Biomaterials; 2011 Dec; 32(36):9940-9. PubMed ID: 21937103
[TBL] [Abstract][Full Text] [Related]
49. The compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid inhibits HIV-1 replication by targeting the enzyme reverse transcriptase.
Souza TM; Cirne-Santos CC; Rodrigues DQ; Abreu CM; Tanuri A; Ferreira VF; Marques IP; de Souza MC; Fontes CF; Frugulhetti IC; Bou-Habib DC
Curr HIV Res; 2008 May; 6(3):209-17. PubMed ID: 18473784
[TBL] [Abstract][Full Text] [Related]
50. Synthesis, anti-HIV, and cytotoxic activity of new AZT conjugates of steroid acids.
You Z; Mian AM; Agarwal RP; Lee HJ
Nucleosides Nucleotides Nucleic Acids; 2003 Nov; 22(11):2049-60. PubMed ID: 14680027
[TBL] [Abstract][Full Text] [Related]
51. Therapeutic strategies towards HIV-1 infection in macrophages.
Perno CF; Svicher V; Schols D; Pollicita M; Balzarini J; Aquaro S
Antiviral Res; 2006 Sep; 71(2-3):293-300. PubMed ID: 16806514
[TBL] [Abstract][Full Text] [Related]
52. S-acyl-2-thioethyl aryl phosphotriester derivatives of AZT: synthesis, antiviral activity, and stability study.
Peyrottes S; Coussot G; Lefebvre I; Imbach JL; Gosselin G; Aubertin AM; Périgaud C
J Med Chem; 2003 Feb; 46(5):782-93. PubMed ID: 12593658
[TBL] [Abstract][Full Text] [Related]
53. Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptase.
Sweeney ZK; Harris SF; Arora SF; Javanbakht H; Li Y; Fretland J; Davidson JP; Billedeau JR; Gleason SK; Hirschfeld D; Kennedy-Smith JJ; Mirzadegan T; Roetz R; Smith M; Sperry S; Suh JM; Wu J; Tsing S; Villaseñor AG; Paul A; Su G; Heilek G; Hang JQ; Zhou AS; Jernelius JA; Zhang FJ; Klumpp K
J Med Chem; 2008 Dec; 51(23):7449-58. PubMed ID: 19007201
[TBL] [Abstract][Full Text] [Related]
54. Potent inhibition of HIV-1 entry by (s4dU)35.
Horváth A; Tokés S; Hartman T; Watson K; Turpin JA; Buckheit RW; Sebestyén Z; Szöllosi J; Benko I; Bardos TJ; Dunn JA; Fésüs L; Tóth FD; Aradi J
Virology; 2005 Apr; 334(2):214-23. PubMed ID: 15780871
[TBL] [Abstract][Full Text] [Related]
55. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
[TBL] [Abstract][Full Text] [Related]
56. HIV antiretroviral drug combination induces endothelial mitochondrial dysfunction and reactive oxygen species production, but not apoptosis.
Jiang B; Hebert VY; Li Y; Mathis JM; Alexander JS; Dugas TR
Toxicol Appl Pharmacol; 2007 Oct; 224(1):60-71. PubMed ID: 17669453
[TBL] [Abstract][Full Text] [Related]
57. Uncharged AZT and D4T derivatives of phosphonoformic and phosphonoacetic acids as anti-HIV pronucleosides.
Shirokova EA; Jasko MV; Khandazhinskaya AL; Ivanov AV; Yanvarev DV; Skoblov YS; Mitkevich VA; Bocharov EV; Pronyaeva TR; Fedyuk NV; Kukhanova MK; Pokrovsky AG
J Med Chem; 2004 Jul; 47(14):3606-14. PubMed ID: 15214788
[TBL] [Abstract][Full Text] [Related]
58. Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1.
Guillemont J; Pasquier E; Palandjian P; Vernier D; Gaurrand S; Lewi PJ; Heeres J; de Jonge MR; Koymans LM; Daeyaert FF; Vinkers MH; Arnold E; Das K; Pauwels R; Andries K; de Béthune MP; Bettens E; Hertogs K; Wigerinck P; Timmerman P; Janssen PA
J Med Chem; 2005 Mar; 48(6):2072-9. PubMed ID: 15771449
[TBL] [Abstract][Full Text] [Related]
59. 1-Aminocyclobutanecarboxylic acid derivatives as novel structural elements in bioactive peptides: application to tuftsin analogs.
Gershonov E; Granoth R; Tzehoval E; Gaoni Y; Fridkin M
J Med Chem; 1996 Nov; 39(24):4833-43. PubMed ID: 8941397
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
